Health New BTK Inhibitor Shows Promise for Chronic Urticaria Treatment Recent clinical trials have highlighted the potential of remibrutinib, a selective inhibitor of Bruton tyrosine kinase (BTK), as a promising treatment for chronic spontaneous... Editorial4 hours ago